Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,702 | 5,884 | 10,460 | 12,980 | 109 |
| Marketable Securities | 3,808 | 3,254 | N/A | N/A | N/A |
| TOTAL | $8,129 | $9,916 | $11,404 | $14,338 | $674 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 2 |
| Other Non-Current Assets | 206 | 224 | 243 | 261 | 279 |
| TOTAL | $206 | $224 | $243 | $262 | $281 |
| Total Assets | $8,335 | $10,140 | $11,647 | $14,600 | $955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 918 | 488 | 886 | 1,347 | 1,226 |
| Accrued Expenses | 1,430 | 731 | 694 | 985 | 847 |
| Other current liabilities | 97 | 94 | 91 | N/A | 105 |
| TOTAL | $2,445 | $1,313 | $1,671 | $2,427 | $2,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 14 |
| Other Non-Current Liabilities | 72 | 98 | 123 | 0 | 170 |
| TOTAL | $72 | $98 | $123 | $146 | $184 |
| Total Liabilities | $2,517 | $1,411 | $1,794 | $2,573 | $2,409 |
| Shareholders' Equity | |||||
| Retained earnings | -21,902 | -18,806 | -17,549 | -15,237 | -12,599 |
| Other shareholders' equity | -2 | -1 | 0 | 0 | 0 |
| TOTAL | $5,818 | $8,729 | $9,853 | $12,027 | $-1,454 |
| Total Liabilities And Equity | $8,335 | $10,140 | $11,647 | $14,600 | $955 |